In endometrial cancer development, lncRNA LA16C-313D11.11 acts as a ceRNA in the miR-205-5p–PTEN axis by inhibiting miR-205-5p and thereby increasing the expression of PTEN [168]. This evidence concerns the gene PTEN and endometrial cancer.